Investor directory
Monograph Capital
Monograph Capital invests in early to growth-stage healthcare companies that are innovating in therapeutics and diagnostics.
What they invest in
Sectors
Geographies
United KingdomGermanyUnited States
The facts
- Headquarters
- London, United Kingdom
- Founded
- 2021
Selected portfolio
Ouro MedicinesRQ BioOllinHI-BioAutobahn TherapeuticsOdaiaProLynxAscend (Drug Discovery)Nocion TherapeuticsElevara MedicinesSudo BiosciencesMiroBioRegASKAscendAutobahnAviadoBioMaxion Therapeutics
Does Monograph Capital fit your round?
In 30 minutes you'll know which funds matter for your round.
Book a callAre you Monograph Capital? Tell us what to correct and we will update it — or ask us to remove the entry.